Member Info for BigYellowPig

this wasnt a spike. I mean the spikes that take us to 10% on nothing.

No Harchris, I didnt sell out earlier. Although I admit I know the movements of this stock much better than you it would seem.

Everyone learns the hard way. They think they enter at the bottom only to sell on a loss. Thank the rampers.

Harchris….how do you know that most of the staff are on temporary contracts? I hope you aren’t basing that on the few job adverts. They could be for natural attrition for all we know so there will still be many full timers in employment.

I was saying that about the cash position yesterday, there is nothing to back the figures up. Yet everyone is saying we have £100m in the bank. Does that include payment for the second LTIP tranche, trade receivables, tax reclaim?.

The real figures that we have been told is as per that graph. So as I said yesterday, the £100m cash means nothing.

@Butcher ….I’ve never changed, I go off of the latest data rather than ramping and letting folks like you trap new investors. If you want to blame someone from going bull to bear, why don’t you take it out on Graham Mullis and Dave Allmond, the real culprits. If you think the last RSN was positive let me know now so I block you as you completely clueless or just trading.

The GLP damaged the UK diagnostics sector. It’s a party politics game only. If Jo Maugham was worried about all contracts, he would have taken the government to court over the FDA banned Innova products but he’s pro China/America so not in his interest.

Harchris- our cash position grew by £10m in 2021 (that could be a tax rebate for all we know), but on £97m of revenues, why is the cash position so low. I’m concerned that the cost of sales could wipe out our cash position in 2022. New Non covid products not until Q4, when is that…..Oct 1st or December 31st?

We have been told in previous RNSs the following points:-
- Covid revenues halfing year on year
- Non covid revenues growing 20% year on year

And this looks like the following graph:-
https://twitter.com/fastmoneyaim/status/1486309101193859075?s=21

Would you invest here? The BoD need to do better as these revs will not bring in fresh investors.

Orien….might as well just allow it to sink further, it’s inevitable. Bourse currently showing theoretical opening of 1.980 euros vs yesterday’s close of 2.172. A synchronised attack on Novacyt with the Private Eye, release of DAs poor RNS. A mess to say the least. Any decent company would have suspended the share by now.
https://www.boursorama.com/cours/1rPALNOV/

You are trying to hard, give your brain a rest

Yes more red to look at tomorrow. Night night x

Big yellow pig likes to hear Big hero rises and big hero bigging it up.

It doesn’t make you smarter if you invested yesterday. You invested on a whim and a prayer and trying to make up your loses on YGEN.

You literally invested here today davand. I’ve been here two years. Time you moved on and took the hit for your next rainbow chase. I bet you don’t even know what this company does!

Let me guess, you don’t like the numbers that the company provided today being written out in simple terms for you?

I don’t believe covid is over by a long way. There will still be testing but the competition has killed off Novacyt.

It doesn’t matter how many cases there are, how many new variants, how out of control it grows, we are expecting covid product sales of £40m in 2022 vs £82m in 2021 vs £263m of covid products in 2020. Now that is an 85 percent drop in covid sales in 2020 to those forecast in 2022. Now, does anyone know why the share price has dropped 90 percent in 12 months? Seems pretty obvious doesn’t it.

Sounds like you know how your coke is cut Kaeren. Very insightful.

SP Angel were forecasting 316.2m cash for YE 2021. As per their broker note 21 October 2020. Don’t worry though, we should have 409.3m euros cash in under 12 months!!!

https://novacyt.com/wp-content/uploads/2020/10/2020_Oct_SP_Angel_Novacyt_Initiation_Note_21.10.2020.pdf

Nelliedean - I think you hit the nail on the head when you said ‘what did he do’! He’s in too many companies for a start and is poor and cringeworthy in investor meetings.

He’s a non-exec and chairperson for Novacyt.

Now who thinks James Wakefield is doing his job:-
In basic terms, the Chairman is the head of a board of directors and is in this position because they are elected by the shareholders. The over-arching responsibility of the Chairman is to protect shareholders' interests and ensure the company is run profitably and in a stable fashion.